C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.490
+0.010 (0.29%)
Aug 3, 2026, 10:26 AM EDT - Market open
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $385.88 million as of August 3, 2026. Its market cap has increased by 156.34% in one year.
Market Cap
385.88M
Enterprise Value
174.95M
1-Year Change
156.34%
Ranking
Category
Stock Price
$3.49
ChartMarket Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $385.88M, a decrease of -50.06%. That is a compound annual growth rate of -11.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 385.88M | 108.46% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evommune | 406.50M |
| Larimar Therapeutics | 403.96M |
| vTv Therapeutics | 403.25M |
| Editas Medicine | 400.54M |
| Sutro Biopharma | 400.26M |
| Puma Biotechnology | 387.85M |
| X4 Pharmaceuticals | 381.52M |
| Scribe Therapeutics | 381.44M |